z-logo
Premium
Comparative proteomic analysis provides insight into the key proteins as potential targets underlying the effect of malachite green against Ichthyophthirius multifiliis
Author(s) -
Qu Shenye,
Song Chenguang,
Tan Xiaoping,
Wang Gaoxue,
Ling Fei
Publication year - 2021
Publication title -
journal of fish diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 85
eISSN - 1365-2761
pISSN - 0140-7775
DOI - 10.1111/jfd.13346
Subject(s) - ichthyophthirius multifiliis , biology , ribosome , ribosome inactivating protein , malachite green , proteomics , pi3k/akt/mtor pathway , microbiology and biotechnology , ciliate , computational biology , signal transduction , biochemistry , rna , genetics , fish <actinopterygii> , gene , chemistry , fishery , organic chemistry , adsorption
Abstract Target identification is important for drug discovery. Unfortunately, no drug targets have been found in Ichthyophthirius multifiliis until now and further limited development of the novel drug for Ichthyophthiriasis. In this study, an iTRAQ‐based quantitative proteomic analysis was used to find the target of malachite green (MG), exhibiting greater efficacy than the existing drugs, against I. multifiliis trophonts in situ. We also verified the proteomic results by RT‐qPCR, TEM and cell apoptosis assay. Our results showed that major variations in protein abundance were found among many of the ribosome proteins, indicating ribosome might be a candidate target. Furthermore, GO and KEGG pathway analyses of differentially expressed proteins (DEPs) revealed that ribosome and PI3K‐Akt signalling pathway were remarkably enriched. Taken together, the above DEPs were also verified by RT‐qPCR and morphological observations. This study provides insights into the key proteins enriched in PI3K‐Akt signal pathway and ribosome pathway as potential targets of MG killing I. multifiliis , which could be served as targets for other less toxic drugs and be tested as potential treatments for I. multifiliis .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here